| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
alpha 1,4-galactosyltransferase (P blood group) | 0.751 | 0.346 | 7.7E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
group | 0.340 | None | 1.000 | 5 | 0 | 1994 | 2012 | ||||||||
|
ATP binding cassette subfamily C member 1 | 0.445 | 0.808 | 1.2E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
ATP binding cassette subfamily C member 2 | 0.483 | 0.808 | 5.2E-47 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2012 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2003 | 2018 | ||||||||
|
ArfGAP with FG repeats 2 | 0.700 | 0.423 | 2.5E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2016 | ||||||||
|
A-kinase anchoring protein 13 | 0.626 | 0.615 | 0.93 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2008 | 2017 | ||||||||
|
AKT serine/threonine kinase 2 | 0.474 | 0.769 | 0.64 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 | |||||||||
|
alanyl aminopeptidase, membrane | 0.462 | 0.769 | 3.7E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
Rho GTPase activating protein 24 | 0.456 | 0.808 | 3.9E-10 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1999 | 1999 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
activating transcription factor 2 | 0.551 | 0.808 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
atrophin 1 | 0.409 | 0.885 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
apoptosis and caspase activation inhibitor | 0.760 | 0.231 | 2.7E-09 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
AXL receptor tyrosine kinase | 0.489 | 0.615 | 1.3E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2003 | ||||||||
|
BCL2 binding component 3 | 0.517 | 0.769 | 4.0E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
BAF chromatin remodeling complex subunit BCL11A | 0.541 | 0.769 | 0.97 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
BAF chromatin remodeling complex subunit BCL11B | 0.568 | 0.731 | 0.99 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 |